Cancers (Journal)

Reynolds, P. A. (Member of editorial board)

Activity: Publication peer-review and editorial work types › Peer review of manuscripts

Description

Special Issue Editor: "Advances in the Treatment of Renal Cell Carcinoma"

Period	30 Sept 2020
Type of journal	Journal
ISSN	2072-6694
Degree of Recognition	International

Keywords

renal cell carcinoma
surgery
systemic therapy
combination therapy
resistance
biomarkers

Documents & Links

Renal cell carcinoma (RCC) represents 90% of kidney cancers and around 3% of all malignancies worldwide. Established risk factors for RCC include increasing age, smoking, obesity, and hypertension. The incidence of RCC is rising, partly due to changes in the above risk factors and partly due to the increased detection of asymptomatic RCC by the widespread use of modern abdominal imaging techniques. While there has been a decrease in the number of patients presenting with advanced metastatic RCC, compared to early disease presentation, there remains the significant issue of clinical resistance to current therapies and drug resistance remains a significant health burden. This Special Issue will focus on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.